Zoetis Introduces BRD Solutions
Solutions for bovine respiratory disease in one convenient online resource
PARSIPPANY, N.J., Oct. 10, 2017 — Producers looking to achieve 50% fewer re-treats1 or 81% fewer mortalities2 against bovine respiratory disease (BRD) can get started with BRD Solutions from Zoetis at BRD-Solutions.com.
BRD-Solutions.com can be the comprehensive resource for managing against this disease that causes up to 70% of deaths in feedlots3 and 89% of deaths in stocker operations.4 This interactive website provides producers, and their veterinarians, with information on:
• BRD education to help better understand strategies to combat this complex disease
• Solutions that can help optimize cattle health and well-being
• Good antibiotic stewardship
• Disease management insights from veterinarians and producers
“BRD is already complicated, and our goal is to make a solution feel simple,” said Shawn Blood, DVM, Beef Strategic Technical Services at Zoetis. “When we talk about BRD Solutions, the solution is not necessarily just a product. It may be a product, multiple products, services or just good management practices. As BRD continues to be a costly threat to the health and well-being of cattle, costing the cattle industry around $1 billion each year,[5,6] applying customizable BRD Solutions can help producers and veterinarians meet the needs of their operation to better manage BRD. With BRD Solutions, you’ll be supported with first-in-class vaccines, antimicrobials, feed additives and a very extensive and knowledgeable support staff with Technical Services veterinarians and nutritionists you’ve come to know and expect from Zoetis.”
With the goal of reducing BRD morbidity and mortality in operations, BRD Solutions offers a comprehensive range of BRD management programs from disease prevention to control and treatment of sick cattle when needed. Solutions like effective vaccines are available to avoid costly treatments by helping boost cattle immune response against BRD pathogens, and feed additives can help support animal health with an extra level of protection. And if cattle get sick, a veterinarian can recommend the right class of antimicrobial to help control and treat challenges with BRD unique to the operation. Zoetis offers three different and complementary classes of antimicrobials — Draxxin®(tulathromycin) Injectable Solution, Excede®(ceftiofur crystalline free acid) Sterile Suspension and Advocin®(danofloxacin injection) Sterile Antimicrobial Injectable Solution — that are supported by research that demonstrates efficacy in controlling and treating BRD. The help of these highly effective solutions means you can help optimize treatments needed to remedy BRD and improve animal health, well-being and the responsible use of antibiotics.
With BRD Solutions from Zoetis, it’s possible to take BRD management to the next level and achieve fewer re-treats and reduced mortalities as a result. Get started today at BRD-Solutions.com.
IMPORTANT SAFETY INFORMATION FOR DRAXXIN: DRAXXIN has a pre-slaughter withdrawal time of 18 days in cattle. Do not use in female dairy cattle 20 months of age or older. Do not use in animals known to be hypersensitive to the product. See full Prescribing Information.
IMPORTANT SAFETY INFORMATION FOR EXCEDE: People with known hypersensitivity to penicillin or cephalosporins should avoid exposure to EXCEDE. EXCEDE is contraindicated in animals with known allergy to ceftiofur or to the ß-lactam group (penicillins and cephalosporins) of antimicrobials. Inadvertent intra-arterial injection is possible and fatal. Do not use in calves to be processed for veal. Pre-slaughter withdrawal time is 13 days following the last dose. See full Prescribing Information.
IMPORTANT SAFETY INFORMATION FOR ADVOCIN: Extra-label use of ADVOCIN in food-producing animals is prohibited. Do not use in cattle intended for dairy production or in calves to be processed for veal. ADVOCIN has a pre-slaughter withdrawal time of four days. See full Prescribing Information.
Zoetis is the leading animal health company, dedicated to supporting its customers and their businesses. Building on more than 60 years of experience in animal health, Zoetis discovers, develops, manufactures and markets veterinary vaccines and medicines, complemented by diagnostic products, genetic tests, biodevices and a range of services. Zoetis serves veterinarians, livestock producers and people who raise and care for farm and companion animals with sales of its products in more than 100 countries. In 2016, the company generated annual revenue of $4.9 billion with approximately 9,000 employees. For more information, visit www.zoetisUS.com.
For further information, Please contact:
Leona Ling Ferguson
1 Data on file, Study Report Nos. 1133R-60-05-491, A131R-US-12-028, 2132T-60-01-050, 1133R-60-02-376, 2132T-60-01-063, 1133R-60-03-388 and 11RGDRA01, Zoetis Inc.
2 Data on file, Study Report No. 11RGDRA01, Zoetis Inc.
3 Brooks KR, Raper KC, Ward CE, Holland BP, Krehbiel CR, Step DL. Economic Effects of Bovine Respiratory Disease on Feedlot Cattle During Backgrounding and Finishing Phases. http://pods.dasnr.okstate.edu/docushare/dsweb/Get/Document-6830/P-1027 Economic Effect of BRD1.pdf. Accessed August 8, 2017.
4 Clay D. Finding a cure for the common calf — Bovine respiratory disease vaccine may save industry millions. The Oklahoman. July 1, 2003. http://newsok.com/article/1935492. Accessed August 8, 2017.
5 Brodersen BW. Bovine respiratory syncytial virus. Vet Clin North Am Food Anim Pract. 2010;26(2):323-333.
6 Griffin D, Chengappa MM, Kuszak J, McVey DS. Bacterial pathogens of the bovine respiratory disease complex. Vet Clin North Am Food Anim Pract. 2010;26(2):381-394.
- Belgium (French)
- Belgium (Dutch)
- Costa Rica
- Czech Republic
- New Zealand
- South Africa
- South Korea
- United Kingdom
- United States